RAGIV GANDHI UNIVERSITY OF HEALTH SCIENCES

Rheumatoid arthritis is a systemic auto-immune disorder. Auto-immune disorders such as RA offer a growth opportunity for pharmaceutical companies, having a patient potential requiring a chronic treatment approach often with high cost and novel biologics. The pharma industry today is turning its development focus towards auto-immune treatments. ................
................